These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 26283028)
1. Response to the Letter Entitled "Comments Concerning Comparison of Airway and Systemic Malondialdehyde Levels for Assessment of Oxidative Stress in Cystic Fibrosis". Antus B; Barta I Lung; 2015 Oct; 193(5):861-2. PubMed ID: 26283028 [No Abstract] [Full Text] [Related]
2. Comments Concerning "Comparison of Airway and Systemic Malondialdehyde Levels for Assessment of Oxidative Stress in Cystic Fibrosis". Khoubnasabjafari M; Ansarin K; Jouyban A Lung; 2015 Oct; 193(5):867-8. PubMed ID: 26238860 [No Abstract] [Full Text] [Related]
3. Comparison of Airway and Systemic Malondialdehyde Levels for Assessment of Oxidative Stress in Cystic Fibrosis. Antus B; Drozdovszky O; Barta I; Kelemen K Lung; 2015 Aug; 193(4):597-604. PubMed ID: 25951912 [TBL] [Abstract][Full Text] [Related]
4. [Markers of oxidative damage in blood of children with cystic fibrosis]. Chełchowska M; Laskowska-Klita T; Nowaczewska I; Narolewska U Pol Merkur Lekarski; 2002 Aug; 13(74):123-5. PubMed ID: 12420342 [TBL] [Abstract][Full Text] [Related]
5. Increased plasma fatty acid concentrations after respiratory exacerbations are associated with elevated oxidative stress in cystic fibrosis patients. Wood LG; Fitzgerald DA; Gibson PG; Cooper DM; Garg ML Am J Clin Nutr; 2002 Apr; 75(4):668-75. PubMed ID: 11916752 [TBL] [Abstract][Full Text] [Related]
7. Oxidative stress in stable cystic fibrosis patients: do we need higher antioxidant plasma levels? Lezo A; Biasi F; Massarenti P; Calabrese R; Poli G; Santini B; Bignamini E J Cyst Fibros; 2013 Jan; 12(1):35-41. PubMed ID: 22781546 [TBL] [Abstract][Full Text] [Related]
8. Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation. Lagrange-Puget M; Durieu I; Ecochard R; Abbas-Chorfa F; Drai J; Steghens JP; Pacheco Y; Vital-Durand D; Bellon G Pediatr Pulmonol; 2004 Jul; 38(1):43-9. PubMed ID: 15170872 [TBL] [Abstract][Full Text] [Related]
9. Evidence for increased oxidative damage in patients with cystic fibrosis. Brown RK; Kelly FJ Pediatr Res; 1994 Oct; 36(4):487-93. PubMed ID: 7816524 [TBL] [Abstract][Full Text] [Related]
10. [Serum and sputum eosinophil cationic protein levels and clinical status in cystic fibrosis patients]. Korzeniewska A; Sołoniewicz A; Stelmach P; Sobocińska A; Stelmach I Pneumonol Alergol Pol; 2006; 74(4):372-6. PubMed ID: 17427145 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Richman-Eisenstat JB; Jorens PG; Hébert CA; Ueki I; Nadel JA Am J Physiol; 1993 Apr; 264(4 Pt 1):L413-8. PubMed ID: 8476069 [TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of defensins from cystic fibrosis sputum. Soong LB; Ganz T; Ellison A; Caughey GH Inflamm Res; 1997 Mar; 46(3):98-102. PubMed ID: 9098722 [TBL] [Abstract][Full Text] [Related]
15. [Dynamics of markers of blood inflammation against the background of antibacterial therapy in children with mucoviscidosis, with the various regimens of intake of pancreatic enzymes]. Kashirskaia NIu; Shmarina GV; Kapranov NI; Pukhal'skiĭ AL Eksp Klin Gastroenterol; 2004; (2):48-52, 109. PubMed ID: 15462322 [TBL] [Abstract][Full Text] [Related]
16. Sputum and serum calprotectin are useful biomarkers during CF exacerbation. Gray RD; Imrie M; Boyd AC; Porteous D; Innes JA; Greening AP J Cyst Fibros; 2010 May; 9(3):193-8. PubMed ID: 20299288 [TBL] [Abstract][Full Text] [Related]
18. Oxidative Stress Markers in Sputum. Antus B Oxid Med Cell Longev; 2016; 2016():2930434. PubMed ID: 26885248 [TBL] [Abstract][Full Text] [Related]
19. Improvement of nutrient absorption may enhance systemic oxidative stress in cystic fibrosis patients. Shmarina GV; Pukhalsky AL; Kokarovtseva SN; Pukhalskaya DA; Kalashnikova EA; Kapranov NI; Kashirskaja NJ Mediators Inflamm; 2001 Apr; 10(2):61-7. PubMed ID: 11405551 [TBL] [Abstract][Full Text] [Related]
20. The relationship of clinical and inflammatory markers to outcome in stable patients with cystic fibrosis. Downey DG; Martin SL; Dempster M; Moore JE; Keogan MT; Starcher B; Edgar J; Bilton D; Elborn JS Pediatr Pulmonol; 2007 Mar; 42(3):216-20. PubMed ID: 17238189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]